USRE39069E1 - Multi-layered osmotic device - Google Patents
Multi-layered osmotic device Download PDFInfo
- Publication number
- USRE39069E1 USRE39069E1 US10/004,772 US477201A USRE39069E US RE39069 E1 USRE39069 E1 US RE39069E1 US 477201 A US477201 A US 477201A US RE39069 E USRE39069 E US RE39069E
- Authority
- US
- United States
- Prior art keywords
- active agent
- osmotic device
- agent
- core
- semipermeable membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Description
Claims (54)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/004,772 USRE39069E1 (en) | 1997-05-30 | 2001-12-03 | Multi-layered osmotic device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP970102351A AR007358A1 (en) | 1997-05-30 | 1997-05-30 | A MULTILAYER OSMOTIC DEVICE FOR THE CONTROLLED SUPPLY OF ONE OR MORE ACTIVE AGENTS TO ONE OR MORE USE ENVIRONMENTS. |
US09/086,871 US6004582A (en) | 1997-05-30 | 1998-05-29 | Multi-layered osmotic device |
US10/004,772 USRE39069E1 (en) | 1997-05-30 | 2001-12-03 | Multi-layered osmotic device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/086,871 Reissue US6004582A (en) | 1997-05-30 | 1998-05-29 | Multi-layered osmotic device |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE39069E1 true USRE39069E1 (en) | 2006-04-18 |
Family
ID=58544600
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/086,871 Ceased US6004582A (en) | 1997-05-30 | 1998-05-29 | Multi-layered osmotic device |
US10/004,772 Expired - Lifetime USRE39069E1 (en) | 1997-05-30 | 2001-12-03 | Multi-layered osmotic device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/086,871 Ceased US6004582A (en) | 1997-05-30 | 1998-05-29 | Multi-layered osmotic device |
Country Status (13)
Country | Link |
---|---|
US (2) | US6004582A (en) |
EP (1) | EP0914098B1 (en) |
JP (2) | JP3950175B2 (en) |
CN (1) | CN1158071C (en) |
AT (1) | ATE250929T1 (en) |
AU (1) | AU7706598A (en) |
BR (1) | BRPI9802144B1 (en) |
CA (1) | CA2261787C (en) |
DE (1) | DE69818607T2 (en) |
ES (1) | ES2203963T3 (en) |
HK (1) | HK1019859A1 (en) |
IL (1) | IL128043A (en) |
WO (1) | WO1998053802A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050053653A1 (en) * | 2003-09-05 | 2005-03-10 | Argaw Kidane | Osmotic delivery of therapeutic compounds by solubility enhancement |
US20050208132A1 (en) * | 2002-07-29 | 2005-09-22 | Gayatri Sathyan | Methods and dosage forms for reducing side effects of benzisozazole derivatives |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
US20080085311A1 (en) * | 2006-10-05 | 2008-04-10 | Tripathi Sanjay S | Antihistamine-decongestant combinations |
US20090202631A1 (en) * | 2002-07-29 | 2009-08-13 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US20100143471A1 (en) * | 2007-03-21 | 2010-06-10 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
US20100166810A1 (en) * | 2007-07-01 | 2010-07-01 | Joseph Peter Habboushe | Combination tablet with chewable outer layer |
US8632489B1 (en) | 2011-12-22 | 2014-01-21 | A. Mateen Ahmed | Implantable medical assembly and methods |
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US9226891B2 (en) | 2011-10-28 | 2016-01-05 | Vitalis Llc | Anti-flush compositions |
US9381112B1 (en) | 2011-10-06 | 2016-07-05 | William Eric Sponsell | Bleb drainage device, ophthalmological product and methods |
US9616029B2 (en) | 2014-03-26 | 2017-04-11 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release coated reservoir solid dosage form |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Families Citing this family (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100827254B1 (en) * | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | Methods and devices for providing prolonged drug therapy |
ATE286725T1 (en) * | 1998-10-01 | 2005-01-15 | Novartis Pharma Gmbh | NEW ORAL MEDICINAL PREPARATIONS FOR RIVASTIGMINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
CA2346001C (en) * | 1998-10-01 | 2003-12-30 | Elan Pharma International, Limited | Controlled release nanoparticulate compositions |
US8293277B2 (en) | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
EP1244430A4 (en) * | 1999-03-29 | 2004-01-14 | Wyeth Corp | Coating system |
JP4790950B2 (en) | 1999-06-14 | 2011-10-12 | コスモ・テクノロジーズ・リミテッド | Controlled release and taste-masked oral pharmaceutical composition |
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
US20090104273A1 (en) * | 1999-06-22 | 2009-04-23 | Elan Pharma International Ltd. | Novel nifedipine compositions |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
GB9923045D0 (en) * | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
US6346231B1 (en) * | 1999-10-06 | 2002-02-12 | Joar Opheim | Flavored gelatin capsule and method of manufacture |
BR0007360A (en) * | 1999-12-23 | 2001-08-14 | Johnson & Johnson | Controlled release composition |
KR100523127B1 (en) * | 1999-12-23 | 2005-10-20 | 화이자 프로덕츠 인코포레이티드 | Hydrogel-driven drug dosage form |
JP2003518487A (en) | 1999-12-23 | 2003-06-10 | ファイザー・プロダクツ・インク | Hydrogel-driven laminated drug formulation |
WO2001047557A1 (en) * | 1999-12-28 | 2001-07-05 | Ajinomoto Co., Inc. | Oral preparations for diabetes |
US6248359B1 (en) * | 2000-01-05 | 2001-06-19 | Laboratorios Phoenix U.S.A., Inc. | Multi-tablet oxybutynin system for treating incontinence |
US7147870B2 (en) * | 2000-01-13 | 2006-12-12 | Osmotica Corp. | Osmotic device containing pseudoephedrine and an H1 antagonist |
US6613357B2 (en) * | 2000-01-13 | 2003-09-02 | Osmotica Corp. | Osmotic device containing pseudoephedrine and an H1 antagonist |
US6521255B2 (en) | 2000-01-13 | 2003-02-18 | Osmotica Corp. | Osmotic device containing ranitidine and a prokinetic agent |
US6569456B2 (en) * | 2000-01-13 | 2003-05-27 | Osmotica Corp. | Osmotic device containing diltiazem and an ACE inhibitor or diuretic |
US6599532B2 (en) * | 2000-01-13 | 2003-07-29 | Osmotica Corp. | Osmotic device containing alprazolam and an antipsychotic agent |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
WO2001051039A1 (en) * | 2000-01-13 | 2001-07-19 | Osmotica Corp. | Osmotic device containing ranitidine and a prokinetic agent |
US6491949B2 (en) | 2000-01-14 | 2002-12-10 | Osmotica Corp. | Osmotic device within an osmotic device |
AR026148A1 (en) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | OSMOTIC DEVICE WITH PREFORMED PASSAGE THAT INCREASES SIZE |
GB0007419D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Gmbh | Composition |
US6551617B1 (en) * | 2000-04-20 | 2003-04-22 | Bristol-Myers Squibb Company | Taste masking coating composition |
US20040156872A1 (en) * | 2000-05-18 | 2004-08-12 | Elan Pharma International Ltd. | Novel nimesulide compositions |
US6770297B1 (en) * | 2000-05-26 | 2004-08-03 | Unitech Pharmaceuticals, Inc. | Controlled release delivery system of solid dosage form |
TWI290053B (en) * | 2000-09-19 | 2007-11-21 | Daiichi Seiyaku Co | Medicinal composition for preventing the generation of a disagreeable taste |
US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
ATE469644T1 (en) * | 2000-11-17 | 2010-06-15 | Takeda Pharmaceutical | PHARMACEUTICAL PREPARATION CONTAINING N-Ä2-(1,6, 7,8-TETRAHYDRO-2H-INDENOÄ5,4 BUFURAN-8-YL)ETHYLUPROPIONAMIDE COATED WITH A COPOLYVIDONE-CONTAINING, POLYETHYLENE GLYCOL-FREE COATING |
WO2002056863A2 (en) * | 2000-12-29 | 2002-07-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
JP4184082B2 (en) | 2001-01-03 | 2008-11-19 | ボシュ・アンド・ロム・インコーポレイテッド | Sustained release drug delivery device with multiple drugs |
CA2433032C (en) * | 2001-01-03 | 2008-11-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with coated drug cores |
CA2725833A1 (en) * | 2001-01-12 | 2002-07-18 | Sun Pharmaceutical Industries Limited | Spaced drug delivery system |
US20030143272A1 (en) * | 2001-03-14 | 2003-07-31 | Waterman Kenneth C. | Pharmaceutical tablet and process for making thereof |
ATE330586T1 (en) * | 2001-03-14 | 2006-07-15 | Pfizer Prod Inc | PHARMACEUTICAL TABLET AND METHOD FOR PRODUCING THE SAME |
EP1372605A2 (en) * | 2001-03-27 | 2004-01-02 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
DK1377276T3 (en) * | 2001-04-10 | 2012-01-02 | Sun Pharma Advanced Res Co Ltd | Calculation of pulse-release composition |
US6838093B2 (en) * | 2001-06-01 | 2005-01-04 | Shire Laboratories, Inc. | System for osmotic delivery of pharmaceutically active agents |
US7938277B2 (en) | 2001-08-24 | 2011-05-10 | Dober Chemical Corporation | Controlled release of microbiocides |
WO2003020265A2 (en) * | 2001-09-03 | 2003-03-13 | Dsm Ip Assets B.V. | Compositions comprising pectin and ascorbic acid |
AU2002319893A1 (en) * | 2001-09-25 | 2003-04-07 | J.B. Chemicals And Pharmaceuticals Ltd. | Floating osmotic device for controlled release drug delivery |
EP1450783A1 (en) * | 2001-10-08 | 2004-09-01 | Sun Pharmaceuticals Industries Ltd. | New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma |
US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
US8329217B2 (en) | 2001-11-06 | 2012-12-11 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dual controlled release dosage form |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
EP1492509A1 (en) * | 2001-12-18 | 2005-01-05 | ALZA Corporation | Dosage form providing time-varying patterns of drug delivery |
EP1467717A1 (en) * | 2002-01-15 | 2004-10-20 | Ranbaxy Laboratories Limited | Stable pharmaceutical compositions comprising ace inhibitor(s) |
KR100540035B1 (en) * | 2002-02-01 | 2005-12-29 | 주식회사 태평양 | Multi-stage oral drug controlled-release system |
WO2003066021A2 (en) | 2002-02-04 | 2003-08-14 | Elan Pharma International, Ltd. | Drug nanoparticles with lysozyme surface stabiliser |
ITMI20020514A1 (en) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF ONE OR MORE ACTIVE PRINCIPLES |
ITMI20020515A1 (en) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | SYSTEM FOR THE CONTROLLED RELEASE OF ONE OR MORE ACTIVE INGREDIENTS |
AU2003224890A1 (en) * | 2002-04-08 | 2003-10-27 | Lavipharm Laboratories Inc. | Drug-complex microparticles and methods of making/using same |
US8956160B2 (en) * | 2002-07-02 | 2015-02-17 | Ranir, Llc | Device and method for delivering an oral care agent |
US20040258757A1 (en) * | 2002-07-16 | 2004-12-23 | Elan Pharma International, Ltd. | Liquid dosage compositions of stable nanoparticulate active agents |
KR100456833B1 (en) * | 2002-08-01 | 2004-11-10 | 주식회사 대웅 | Cored tablets containing amoxycillin and clavulanate |
EP1545461A4 (en) * | 2002-09-09 | 2011-06-22 | Endo Pharmaceuticals Inc | Combined immediate release and extended release analgesic composition |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
KR20050088311A (en) * | 2002-12-11 | 2005-09-05 | 화이자 프로덕츠 인크. | Controlled-release of an active substance into a high fat environment |
WO2004056359A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Products Inc. | Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
US20070077301A1 (en) * | 2002-12-23 | 2007-04-05 | Meyer Glenn A | Venlafaxine osmotic device formulation |
US8293799B2 (en) * | 2003-12-29 | 2012-10-23 | Osmotica Keresleedelmo és Szolgáltató KFT | Osmotic device containing a venlafaxine salt and a salt having an ion in common |
US7524515B2 (en) * | 2003-01-10 | 2009-04-28 | Mutual Pharmaceuticals, Inc. | Pharmaceutical safety dosage forms |
JP2004231520A (en) * | 2003-01-28 | 2004-08-19 | Nichiko Pharmaceutical Co Ltd | Medicinal composition having excellent preservation stability and elution rate |
US20060210633A1 (en) * | 2003-04-03 | 2006-09-21 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
EP1617785A2 (en) * | 2003-04-14 | 2006-01-25 | Shire Laboratories Inc. | Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem |
US8029822B2 (en) * | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
US20060177507A1 (en) * | 2003-05-22 | 2006-08-10 | Joaquina Faour | Controlled release device containing lercanidipine |
KR100473422B1 (en) * | 2003-06-12 | 2005-03-14 | 박원봉 | A composition for an enteric coating of natural product containing lectin |
DE10328666A1 (en) * | 2003-06-26 | 2005-01-13 | Bayer Healthcare Ag | Tablets containing flavorings and / or flavorings |
US20050013869A1 (en) * | 2003-07-18 | 2005-01-20 | Chaw Cheng Shu | Sustained release formulation for carbamates and a method therefor |
MEP3608A (en) | 2003-08-08 | 2011-05-10 | Biovail Lab Int Srl | Modified-release tablet of bupropion hydrochloride |
AU2004314693B2 (en) | 2003-09-26 | 2011-04-07 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
KR20060115860A (en) * | 2003-09-26 | 2006-11-10 | 알자 코포레이션 | Oros push-stick for controlled delivery of active agents |
JP2007506775A (en) * | 2003-09-26 | 2007-03-22 | アルザ・コーポレーシヨン | Controlled release formulations exhibiting incremental release rates |
ATE493981T1 (en) * | 2003-11-04 | 2011-01-15 | Supernus Pharmaceuticals Inc | ONCE DAILY DOSAGE FORMS OF TROSPIUM |
US8709476B2 (en) | 2003-11-04 | 2014-04-29 | Supernus Pharmaceuticals, Inc. | Compositions of quaternary ammonium compounds containing bioavailability enhancers |
US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
US20050129764A1 (en) * | 2003-12-11 | 2005-06-16 | Vergez Juan A. | Osmotic device containing licofelone |
US20050136116A1 (en) * | 2003-12-18 | 2005-06-23 | Keith Whitehead | Stabilized prednisolone sodium phosphate solutions |
US7670624B2 (en) * | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
SI1566173T1 (en) * | 2004-02-20 | 2006-12-31 | Mattern Udo | Pharmaceutical composition for oral application and method for preparing thereof |
AU2005247195A1 (en) * | 2004-05-27 | 2005-12-08 | Dexcel Pharma Technologies Ltd | Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
US20060008527A1 (en) * | 2004-07-09 | 2006-01-12 | Yury Lagoviyer | Controlled phase composition technology as an improved process for protection of drugs |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20060099550A1 (en) * | 2004-11-10 | 2006-05-11 | Ranir/Dcp Corporation | Device and method for delivering an oral care agent |
US8574626B2 (en) | 2004-12-03 | 2013-11-05 | Osmotica Kereskedelmi és Szolgáltató KFT | Osmotic device containing amantadine and an osmotic salt |
AR053986A1 (en) | 2004-12-03 | 2007-05-30 | Osmotica Pharmaceutical Argent | OSMOTIC DEVICE CONTAINING AMANTADINE AND AN OSMOTIC SALT |
US8252331B2 (en) * | 2004-12-03 | 2012-08-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Osmotic device containing amantadine and an osmotic salt |
US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
JP2008528607A (en) * | 2005-01-26 | 2008-07-31 | エラン・ファルマ・インターナショナル・リミテッド | Controlled regulatory composition comprising an antipsychotic |
WO2006085128A1 (en) * | 2005-02-09 | 2006-08-17 | Wockhardt Limited | Cardiovascular therapeutic combinations |
US7994220B2 (en) | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
WO2007059372A2 (en) * | 2005-11-09 | 2007-05-24 | St. Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
BRPI0620863A8 (en) * | 2005-12-29 | 2018-01-16 | Osmotica Kereskedelmi Es Szolgaltato Kft | triple-release combination tablet |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
WO2008001311A2 (en) * | 2006-06-26 | 2008-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate |
BRPI0712960A2 (en) * | 2006-06-30 | 2012-04-17 | Teva Pharma | pharmaceutical compounds including a combination of piperidinoalkanol and decongestant |
US8124598B2 (en) * | 2006-09-14 | 2012-02-28 | Sharon Sageman | 7-keto DHEA for psychiatric use |
CN100584319C (en) * | 2006-10-16 | 2010-01-27 | 北京科信必成医药科技发展有限公司 | Multiple apertures releasing osmosis pump control release tablet and preparation process thereof |
US7731604B2 (en) * | 2006-10-31 | 2010-06-08 | Taylor Made Golf Company, Inc. | Golf club iron head |
WO2008105920A1 (en) * | 2007-02-28 | 2008-09-04 | Collegium Pharmaceutical, Inc. | Antihistamine combination |
ES2438267T3 (en) * | 2007-08-15 | 2014-01-16 | Mcneil-Ppc, Inc. | Dosing regimen of ibuprofen immediate release and sustained release |
US20100160274A1 (en) * | 2007-09-07 | 2010-06-24 | Sharon Sageman | 7-KETO DHEA for Psychiatric Use |
AU2009204360B2 (en) * | 2008-01-04 | 2014-12-18 | Src, Inc. | The use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound and single dose compositions thereof |
JP2009256237A (en) * | 2008-04-16 | 2009-11-05 | Daiichi Sankyo Healthcare Co Ltd | Solid preparation |
US7883638B2 (en) * | 2008-05-27 | 2011-02-08 | Dober Chemical Corporation | Controlled release cooling additive compositions |
US8591747B2 (en) | 2008-05-27 | 2013-11-26 | Dober Chemical Corp. | Devices and methods for controlled release of additive compositions |
US20090294379A1 (en) * | 2008-05-27 | 2009-12-03 | Dober Chemical Corporation | Controlled release of additive compositions |
US8702995B2 (en) | 2008-05-27 | 2014-04-22 | Dober Chemical Corp. | Controlled release of microbiocides |
AU2009279372A1 (en) | 2008-08-06 | 2010-02-11 | Gosforth Centre (Holdings) Pty Ltd | Compositions and methods for treating psychiatric disorders |
AU2009308885A1 (en) * | 2008-10-31 | 2010-05-06 | Mcneil-Ppc, Inc. | Osmotic tablet with a compressed outer coating |
DE102008059206A1 (en) * | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic |
WO2010140111A1 (en) | 2009-06-02 | 2010-12-09 | Ranbaxy Laboratories Limited | Pharmaceutical compositions containing a combination of an antihistamine and a decongestant |
JP5609105B2 (en) * | 2009-12-24 | 2014-10-22 | ライオン株式会社 | Ranitidine-containing coated particles and method for producing the same |
US20130230586A1 (en) | 2010-10-02 | 2013-09-05 | Link Research & Grants Corporation | Treatment of Tinnitus and Related Auditory Dysfunctions |
US9937335B2 (en) * | 2011-06-06 | 2018-04-10 | Oak Crest Institute Of Science | Drug delivery device employing wicking release window |
DE102011051653A1 (en) * | 2011-07-07 | 2013-01-10 | Lts Lohmann Therapie-Systeme Ag | Swellable coated tablet |
GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
BR112014006356B1 (en) | 2011-09-19 | 2022-01-18 | Orexo Ab | SUBLINGUAL PILL, PROCESS FOR PREPARING IT AND ITS USE |
CN102696587B (en) * | 2012-06-15 | 2014-03-26 | 河南好年景生物发展有限公司 | Compound controlled-release granular pesticide preparation and preparation method thereof |
WO2014102741A2 (en) * | 2012-12-28 | 2014-07-03 | University Of The Witwatersrand, Johannesburg | Pharmaceutical dosage form |
JP6114571B2 (en) * | 2013-01-23 | 2017-04-12 | 高砂熱学工業株式会社 | Antibacterial equipment for running water equipment |
WO2015073736A1 (en) | 2013-11-13 | 2015-05-21 | Arbor Pharmaceuticals, Llc | Methods and compositions for treating adhd |
US20180362974A1 (en) | 2015-07-02 | 2018-12-20 | University Of Louisville Research Foundation, Inc. | EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER |
WO2018118496A1 (en) | 2016-12-20 | 2018-06-28 | Colgate-Palmolive Company | Oral care composition |
RU2735733C1 (en) | 2016-12-20 | 2020-11-06 | Колгейт-Палмолив Компани | Oral care composition |
WO2019023617A1 (en) * | 2017-07-27 | 2019-01-31 | University Of Utah Research Foundation | Therapeutic delivery device |
US10213394B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US20190247331A1 (en) | 2018-02-15 | 2019-08-15 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US10213393B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság | Composition and method for treating neurological disease |
EP3735228B1 (en) * | 2018-03-05 | 2022-01-05 | Amneal Complex Products Research LLC | Programmable pharmaceutical compositions for chrono drug release |
AU2020363900A1 (en) | 2019-10-08 | 2022-05-26 | Ackley Machine Corporation | Laser etched capsules and methods of making them |
EP4065131A1 (en) * | 2019-11-28 | 2022-10-05 | Caprika Srl | Rectal-use composition for the treatment of constipation |
IL299845A (en) | 2020-07-15 | 2023-03-01 | Schabar Res Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4335099A (en) * | 1975-05-29 | 1982-06-15 | The Green Cross Corporation | Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
US4673405A (en) * | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
US4810502A (en) * | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
US4814183A (en) | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
US5035897A (en) * | 1989-09-05 | 1991-07-30 | Alza Corporation | Dosage form for delivering soluble or insoluble drugs |
US5082668A (en) | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
US5609590A (en) * | 1993-02-25 | 1997-03-11 | Pfizer Inc. | PH-triggered osmotic bursting delivery devices |
US5681584A (en) * | 1993-04-23 | 1997-10-28 | Ciba-Geigy Corporation | Controlled release drug delivery device |
US5713888A (en) | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5951223A (en) * | 1982-09-17 | 1984-03-24 | Sumitomo Chem Co Ltd | Pharmaceutical composition |
IT1200217B (en) * | 1986-09-30 | 1989-01-05 | Valducci Roberto | MEMBRANE FOR PHARMACEUTICAL AND INDUSTRIAL USE |
CA1331563C (en) * | 1987-08-03 | 1994-08-23 | Gaylen M. Zentner | Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins |
JPH07552B2 (en) * | 1987-11-06 | 1995-01-11 | 田辺製薬株式会社 | Long-acting formulation |
CH675537A5 (en) * | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
IT1226940B (en) * | 1988-09-16 | 1991-02-22 | Recordati Chem Pharm | THERAPEUTIC SYSTEM WITH CONTROLLED RELEASE FOR LIQUID PHARMACEUTICAL FORMULATIONS |
ATE109973T1 (en) * | 1989-05-11 | 1994-09-15 | Chugai Pharmaceutical Co Ltd | ORAL PREPARATION FOR ADMINISTRATION TO SPECIFIC SITES OF THE INTESTINE. |
IT1256651B (en) * | 1992-12-11 | 1995-12-12 | Giancarlo Santus | PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE IN LIQUID SUSPENSION |
FR2698560B1 (en) * | 1992-11-30 | 1995-02-03 | Virbac Laboratoires | Stabilized powdery active ingredients, compositions containing them, process for obtaining them and their applications. |
GB9407386D0 (en) * | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
-
1998
- 1998-05-29 AU AU77065/98A patent/AU7706598A/en not_active Abandoned
- 1998-05-29 WO PCT/US1998/011010 patent/WO1998053802A1/en active IP Right Grant
- 1998-05-29 IL IL12804398A patent/IL128043A/en not_active IP Right Cessation
- 1998-05-29 BR BRPI9802144A patent/BRPI9802144B1/en not_active IP Right Cessation
- 1998-05-29 AT AT98925026T patent/ATE250929T1/en not_active IP Right Cessation
- 1998-05-29 DE DE69818607T patent/DE69818607T2/en not_active Expired - Lifetime
- 1998-05-29 ES ES98925026T patent/ES2203963T3/en not_active Expired - Lifetime
- 1998-05-29 CN CNB988007282A patent/CN1158071C/en not_active Expired - Lifetime
- 1998-05-29 EP EP98925026A patent/EP0914098B1/en not_active Expired - Lifetime
- 1998-05-29 US US09/086,871 patent/US6004582A/en not_active Ceased
- 1998-05-29 CA CA002261787A patent/CA2261787C/en not_active Expired - Lifetime
- 1998-05-29 JP JP50097299A patent/JP3950175B2/en not_active Expired - Fee Related
-
1999
- 1999-11-10 HK HK99105177A patent/HK1019859A1/en not_active IP Right Cessation
-
2001
- 2001-12-03 US US10/004,772 patent/USRE39069E1/en not_active Expired - Lifetime
-
2007
- 2007-01-17 JP JP2007007536A patent/JP5059421B2/en not_active Expired - Fee Related
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335099A (en) * | 1975-05-29 | 1982-06-15 | The Green Cross Corporation | Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases |
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
US4673405A (en) * | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US5082668A (en) | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
US4810502A (en) * | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
US4814183A (en) | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
US5035897A (en) * | 1989-09-05 | 1991-07-30 | Alza Corporation | Dosage form for delivering soluble or insoluble drugs |
US5713888A (en) | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
US5609590A (en) * | 1993-02-25 | 1997-03-11 | Pfizer Inc. | PH-triggered osmotic bursting delivery devices |
US5681584A (en) * | 1993-04-23 | 1997-10-28 | Ciba-Geigy Corporation | Controlled release drug delivery device |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050208132A1 (en) * | 2002-07-29 | 2005-09-22 | Gayatri Sathyan | Methods and dosage forms for reducing side effects of benzisozazole derivatives |
US9393192B2 (en) | 2002-07-29 | 2016-07-19 | Alza Corporation | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US20090202631A1 (en) * | 2002-07-29 | 2009-08-13 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US7611728B2 (en) | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
US20050053653A1 (en) * | 2003-09-05 | 2005-03-10 | Argaw Kidane | Osmotic delivery of therapeutic compounds by solubility enhancement |
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US9492443B2 (en) | 2003-11-26 | 2016-11-15 | Acura Pharmaceuticals, Inc. | Abuse deterrent compositions and methods of making same |
US8822489B2 (en) | 2003-11-26 | 2014-09-02 | Acura Pharmaceuticals | Abuse deterrent compositions and methods of making same |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
US20080085311A1 (en) * | 2006-10-05 | 2008-04-10 | Tripathi Sanjay S | Antihistamine-decongestant combinations |
US20100143471A1 (en) * | 2007-03-21 | 2010-06-10 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
US20100166810A1 (en) * | 2007-07-01 | 2010-07-01 | Joseph Peter Habboushe | Combination tablet with chewable outer layer |
US8404275B2 (en) | 2007-07-01 | 2013-03-26 | Vitalis Llc | Combination tablet with chewable outer layer |
US8652520B2 (en) | 2007-07-01 | 2014-02-18 | Vitalis Llc | Combination tablet with chewable outer layer |
US10155044B2 (en) | 2009-09-30 | 2018-12-18 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US11065154B1 (en) | 2011-10-06 | 2021-07-20 | William Eric Sponsel | Bleb drainage device, ophthalmic product and methods |
US9381112B1 (en) | 2011-10-06 | 2016-07-05 | William Eric Sponsell | Bleb drainage device, ophthalmological product and methods |
US9226891B2 (en) | 2011-10-28 | 2016-01-05 | Vitalis Llc | Anti-flush compositions |
US8632489B1 (en) | 2011-12-22 | 2014-01-21 | A. Mateen Ahmed | Implantable medical assembly and methods |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US10441657B2 (en) | 2012-11-30 | 2019-10-15 | Abuse Deterrent Pharmaceuticals, Llc | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US10688184B2 (en) | 2012-11-30 | 2020-06-23 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US9320796B2 (en) | 2012-11-30 | 2016-04-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US11857629B2 (en) | 2012-11-30 | 2024-01-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US9980917B2 (en) | 2014-03-26 | 2018-05-29 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release coated reservoir solid dosage form |
US9616029B2 (en) | 2014-03-26 | 2017-04-11 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release coated reservoir solid dosage form |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Also Published As
Publication number | Publication date |
---|---|
AU7706598A (en) | 1998-12-30 |
DE69818607T2 (en) | 2004-07-29 |
EP0914098A4 (en) | 2001-12-19 |
DE69818607D1 (en) | 2003-11-06 |
JP3950175B2 (en) | 2007-07-25 |
BR9802144A (en) | 1999-05-25 |
CN1228020A (en) | 1999-09-08 |
CA2261787C (en) | 2006-11-14 |
ES2203963T3 (en) | 2004-04-16 |
BRPI9802144B1 (en) | 2017-03-28 |
EP0914098B1 (en) | 2003-10-01 |
JP5059421B2 (en) | 2012-10-24 |
IL128043A0 (en) | 1999-11-30 |
HK1019859A1 (en) | 2000-03-03 |
JP2007126478A (en) | 2007-05-24 |
CA2261787A1 (en) | 1998-12-03 |
ATE250929T1 (en) | 2003-10-15 |
US6004582A (en) | 1999-12-21 |
JP2000516637A (en) | 2000-12-12 |
EP0914098A1 (en) | 1999-05-12 |
WO1998053802A1 (en) | 1998-12-03 |
IL128043A (en) | 2004-08-31 |
CN1158071C (en) | 2004-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE39069E1 (en) | Multi-layered osmotic device | |
US6599284B2 (en) | Osmotic device having a preformed passageway that increases in size | |
US8029822B2 (en) | Rupturing controlled release device having a preformed passageway | |
US8637080B2 (en) | Rupturing controlled release device comprising a subcoat | |
US6491949B2 (en) | Osmotic device within an osmotic device | |
CA2396258C (en) | Combined diffusion/osmotic pumping drug delivery system | |
US6753011B2 (en) | Combined diffusion/osmotic pumping drug delivery system | |
US20060177507A1 (en) | Controlled release device containing lercanidipine | |
CA2526464C (en) | A rupturing controlled release device having a preformed passageway | |
JP2012162533A (en) | Multi-layered permeation device | |
MXPA98004242A (en) | A compressed dispenser for the controlled supply of agents acti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: OSMOTICA HOLDINGS CORP. A.V.V., PANAMA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OSMOTICA CORP.;REEL/FRAME:026202/0244 Effective date: 20041113 Owner name: OSMOTICA (CYPRUS) LIMITED, CYPRUS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OSMOTICA HOLDINGS CORP. A.V.V.;REEL/FRAME:026202/0710 Effective date: 20041113 Owner name: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, HUNGARY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OSMOTICA (CYPRUS) LIMITED;REEL/FRAME:026202/0506 Effective date: 20041113 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, HUNGARY Free format text: ASSIGNEE CHANGE OF ADDRESS;ASSIGNOR:OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT;REEL/FRAME:031692/0741 Effective date: 20120213 |
|
AS | Assignment |
Owner name: CIT BANK, N.A., AS COLLATERAL AGENT, NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG;REEL/FRAME:037656/0777 Effective date: 20160203 |